HTFL

Heartflow, Inc. Common Stock

Healthcare · $4.3B market cap

We can't put a fair value on HTFL right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?

Equity per share growth—?

Sales growth42.1% a year✓

Free cash flow growth—?

Return on invested capital-44.6%✗

Follow HTFL

Track it on your watchlist and see the full analysis. Free.

Create a free account

Insider activity

Since Sep 2, 2026: no open-market purchases and 3 sales worth $2.0M. Why purchases matter

Sales

Verghese Vikram

Chief Financial Officer · 2026-09-08

Sold

$332K

Verghese Vikram

Chief Financial Officer · 2026-09-03

Sold

$1.4M

Verghese Vikram

Chief Financial Officer · 2026-09-02

Sold

$297K

About Heartflow, Inc. Common Stock

HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single…

Medical - Healthcare Information Services

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works

Verdict

Business quality

Insider activity

Sales

About Heartflow, Inc. Common Stock